Moderna, Inc. beat EPS estimates 100% of the time across 2 reported quarters (2 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-1.97 | $-1.97 | +0.0% | Beat |
| Q12026 FY2026 | $-3.02 | $-1.18 | +60.9% | Beat |
| Q42025 FY2025 | $-2.60 | — | — | Miss |
Back to MRNA overview · MRNA holders · MRNA KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.